Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 7:05 p.m.

    📋 Gritstone bio, Inc. (GRTS) - Financial Results

    Filing Date: 2022-08-04

    Accepted: 2022-08-04 16:41:09

    Event Type: Financial Results

    Event Details:

    Gritstone Oncology Inc (GRTS) Reports Q3 2022 Financial Results Gritstone Oncology Inc (GRTS) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 389
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 65694
      • founder, President and Chief Executive Officer of Gritstone. “We have observed a correlation between molecular response and extended overall survival in multiple subjects with end
      • stage colorectal cancer treated with GRANITE, our individualized neoantigen immunotherapy. Today, we shared data demonstrating that the high neutralizing antibody titers to SARS
      • 2 induced by our self
        • expected in 2H 2023
        • expected in the second half of 2022

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Operating Expenses Loss From Operations 25.17K 58.63K $-33.47K -57.08%
    Operating Expenses Net Loss 25.12K 58.43K $-33.31K -57.01%
    Operating Expenses Net Loss Per Share 0.33 0.68 $-0.35 -51.47%
    Operating Expenses Weighted Average Shares 76.75M 86.36M $-9.61M -11.13%
    Current Assets Prepaid Expenses Other Current Assets 7.79K 7.67K $119.00 +1.55%
    Current Assets Property Equipment Net 22.71K 21.62K $1.09K +5.04%
    Current Liabilities Accounts Payable 2.38K 4.23K $-1.85K -43.71%
    Current Liabilities Accrued Liabilities 2.04K 411.00 $1.62K +395.13%
    Revenue 2.76K 2.84K $-82.00 -2.88%
    Loss from Operations 29.67K 25.17K $4.50K +17.89%
    Interest Income 153.00 48.00 $105.00 +218.75%
    Net Loss 29.52K 25.12K $4.40K +17.51%
    Prepaid Expenses and Other Current Assets 7.79K 7.67K $119.00 +1.55%
    Property and Equipment, Net 22.71K 21.62K $1.09K +5.04%
    Accounts Payable 2.38K 4.23K $-1.85K -43.71%
    Accrued Liabilities 2.04K 411.00 $1.62K +395.13%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Gritstone Oncology Inc
    • CIK: 0001656634
    • Ticker Symbol: GRTS
    • Period End Date: 2022-08-04
    • Document Type: 8-K

Search

News categories